Suchergebnisse - "Pickering, Curtis R"

PubPharm (9)

1

Combined TRIP13 and Aurora Kinase Inhibition Induces Apoptosis in Human Papillomavirus-Driven Cancers

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2022

von Ghosh, S. | Mazumdar, T. | Xu, W. | +9

2

PDK1 Mediates NOTCH1-Mutated Head and Neck Squamous Carcinoma Vulnerability to Therapeutic PI3K/mTOR Inhibition

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2019

von Sambandam, V. | Frederick, M. | Shen, L. | +11

3

Literature-based automated discovery of tumor suppressor p53 phosphorylation and inhibition by NEK2

enthalten in: Proceedings of the National Academy of Sciences of the United States of America | 2018

von Choi, B. | Dayaram, T. | Parikh, N. | +22

4

Comprehensive pharmacogenomic profiling of human papillomavirus-positive and -negative squamous cell carcinoma identifies sensitivity to aurora kinase inhibition in KMT2D mutants

enthalten in: Cancer letters | 2018

von Kalu, N. | Mazumdar, T. | Peng, S. | +9

5

CDKN2A/p16 Deletion in Head and Neck Cancer Cells Is Associated with CDK2 Activation, Replication Stress, and Vulnerability to CHK1 Inhibition

enthalten in: Cancer research | 2018

von Gadhikar, M. | Zhang, J. | Shen, L. | +17

6

Distinct pattern of TP53 mutations in human immunodeficiency virus-related head and neck squamous cell carcinoma

enthalten in: Cancer | 2018

von Gleber-Netto, F. | Zhao, M. | Trivedi, S. | +17

CommentIn: Cancer. 2018 Jan 1;124(1):14-17. - PMID 29053184

7

Mutations of the LIM protein AJUBA mediate sensitivity of head and neck squamous cell carcinoma to treatment with cell-cycle inhibitors

enthalten in: Cancer letters | 2017

von Zhang, M. | Singh, R. | Peng, S. | +11

8

Coordinated targeting of the EGFR signaling axis by microRNA-27a*

enthalten in: Oncotarget | 2013

von Wu, X. | Bhayani, M. | Dodge, C. | +12

9

Chk1/2 inhibition overcomes the cisplatin resistance of head and neck cancer cells secondary to the loss of functional p53

enthalten in: Molecular cancer therapeutics | 2013

von Gadhikar, M. | Sciuto, M. | Alves, M. | +7

1
[1]